David Hines

1.8k citations

30 papers · 766 indexed · h-index 13

Impact in

Applied Microbiology and Biotechnology top 2%
- Antibiotic Use and Resistance
Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria

Papers in

Applied Microbiology and Biotechnology 7
- Antibiotic Use and Resistance 7
Molecular Medicine 5
- Antibiotic Resistance in Bacteria 5

Co-authors: Thomas C. Boone H. Inoue K M Zsebo Arthur M. Cohen L M Souza Shayna Weiner Mark Wolff E. Lucile White
Journals: Open Forum Infectious Diseases (6 papers)Journal of Occupational and Environmental Medicine (4 papers)ACR Open Rheumatology (2 papers)Infection Control and Hospital Epidemiology (2 papers)Clinical Infectious Diseases (1 paper)
Partner nations: United States Netherlands Norway

In The Last Decade

David Hines

27 papers receiving 737 citations

Peers

Countries citing papers authored by David Hines

Since Specialization

Citations

This map shows the geographic impact of David Hines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hines more than expected).

Fields of papers citing papers by David Hines

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hines. The network helps show where David Hines may publish in the future.

Co-authors

The 25 scholars most cited alongside David Hines, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Hines Line = papers co-authored together David Hines links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Association Between Social Determinants of Health, Risk Factors, Job Performance, and Health Care Costs in an Employed Population Journal of Occupational and Environmental Medicine ·Wayne N. Burton, Alyssa B. Schultz, Д. А. Долгих, David Hines	2024	0
2	Anti–Peptidylarginine Deiminase 4 Autoantibodies and Disease Duration as Predictors of Treatment Response in Rheumatoid Arthritis ACR Open Rheumatology ·Laura C. Cappelli, David Hines, Hong Wang, Clifton O. Bingham, Erika Darrah	2023	3
3	Migraine Headache in an Employed Population Journal of Occupational and Environmental Medicine ·Wayne N. Burton, Alyssa B. Schultz, Д. А. Долгих, David Hines	2022	1
4	Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2 Critical Care Explorations ·Russell M. Petrak, 林建彰, H. G. Walther, Ran-Ran Liang, Vishnu Chundi, 近藤仁之, Christianne Connelly, Yuka Takahashi, David Hines	2021	9
5	A North American Cohort of Anti‐SAE Dermatomyositis: Clinical Phenotype, Testing, and Review of Cases ACR Open Rheumatology ·Jemima Albayda, Christopher A. Mecoli, Livia Casciola‐Rosen, Sonye K. Danoff, Cheng Ting Lin, David Hines, Laura Gutierrez‐Alamillo, Julie J. Paik, Eleni Tiniakou, Andrew L. Mammen, Lisa Christopher‐Stine	2021	32
6	Results of a Virtual Migraine Education Program in an Employed Population Journal of Occupational and Environmental Medicine ·Wayne N. Burton, Alyssa B. Schultz, Д. А. Долгих, Adrian Gale, David Hines	2021	1
7	A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline Infectious Diseases and Therapy ·文宣寺久保, Russell M. Petrak, H. G. Walther, Ran-Ran Liang, Michael Anderson, 近藤仁之, Christianne Connelly, 幸雄平, Vishnu Chundi, David Hines, W. S. Wiss, Apoorv Kalra	2020	19
8	Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting International Journal of Infectious Diseases ·Guillermo Rodríguez-Nava, Shi Zenming, 雅荒井, Rika Takeya, Harvey Friedman, David Hines	2020	37
9	Clinical Characteristics and Risk Factors for Death of Hospitalized Patients With COVID-19 in a Community Hospital: A Retrospective Cohort Study SHILAP Revista de lepidopterología ·Guillermo Rodríguez-Nava, Shi Zenming, 雅荒井, Rika Takeya, Lina Agustina, Jens Ejsing, Harvey Friedman, David Hines	2020	10
10	1687. High-Rates of Candida auris Carriage and Co-Colonization with Multidrug-Resistant Organisms (MDROs) Open Forum Infectious Diseases ·V.P. Nakonechny, Parul Patel, Oksana V. Golodniak, Sara Lundberg, Donna Schora, Kathy A. Mangold, Ірина Дахім, David Hines, Boeun Lee, Kamaljit Singh	2019	0
11	The Impact of Worksite Clinics on Teacher Health Care Utilization and Cost, Self-Reported Health Status, and Student Academic Achievement Growth in a Public School District Journal of Occupational and Environmental Medicine ·John Engberg, Hou-Guang He, David Hines, M.Si. Kusnoto, Kara Marie Liu	2018	2
12	Modifiable Risk Factors for the Spread of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Among Long-Term Acute-Care Hospital Patients Infection Control and Hospital Epidemiology ·Koh Okamoto, Michael Y. Lin, Manon Haverkate, Karen Lolans, Nicholas M. Moore, Shayna Weiner, Rosie D. Lyles, Donald Blom, Yoona Rhee, Sarah K. Kemble, Louis Fogg, David Hines, Robert A. Weinstein, Mary K. Hayden	2017	22
13	Chlorhexidine Gluconate (CHG) Susceptibility of Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae Isolates From Skin Cultures of Patients in Long-Term Acute Care Hospitals (LTACHs) Open Forum Infectious Diseases ·Nicholas M. Moore, Karen Lolans, Louis Fogg, Shayna Weiner, Donald Blom, Rosie D. Lyles, Michael Y. Lin, David Hines, Robert A. Weinstein, Mary K. Hayden	2015	0
14	Prevention of Colonization and Infection by Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae in Long-term Acute-Care Hospitals Clinical Infectious Diseases ·Mary K. Hayden, Michael Y. Lin, Karen Lolans, Shayna Weiner, Donald Blom, Nicholas M. Moore, Louis Fogg, David B. Henry, Rosie D. Lyles, Henley M John Smart, Monica K Sikka, David Hines, Robert A. Weinstein	2014	136
15	The Effectiveness of Routine Daily Chlorhexidine Gluconate Bathing in Reducing Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae Skin Burden among Long-Term Acute Care Hospital Patients Infection Control and Hospital Epidemiology ·Michael Y. Lin, Karen Lolans, Donald Blom, Rosie D. Lyles, Shayna Weiner, A. Twardowska, Nicholas M. Moore, David Hines, Robert A. Weinstein, Mary K. Hayden	2014	36
16	Rapid prefractionation of complex protein lysates with centrifugal membrane adsorber units improves the resolving power of 2D-PAGE-based proteome analysis BMC Genomics ·Mary Kathryn Doud, Michael W. Schmidt, David Hines, Huang-Fu Ye, Andreas Kocourek, Noushin Kashani‐Poor, Robert Zeidler, Dieter A Wolf	2004	10
17	Pseudomembranous Tracheobronchitis Caused by Aspergillus American Review of Respiratory Disease ·David Hines, 尹树田, Ting Wu, Нори Нори, Nakeyah Giroux-Works, Alan A. Harris	1991	41
18	Combined APACHE II Score and Serum Lactate Dehydrogenase as Predictors of In-hospital Mortality Caused by First Episode Pneumocystis carinii Pneumonia in Patients with Acquired Immunodeficiency Syndrome American Review of Respiratory Disease ·Constance A. Benson, Joel B. Spear, David Hines, John C. Pottage, Harold A. Kessler, Gordon M. Trenholme	1991	48
19	In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms Antimicrobial Agents and Chemotherapy ·Constance A. Benson, John Segreti, 边伟, David Hines, Larry J. Goodman, R L Kaplan, Gordon M. Trenholme	1987	27
20	Automatic semantic priming: Effect of category exemplar level and word association level. Journal of Experimental Psychology Human Perception & Performance ·David Hines, Mary Czerwinski, Courtney D. Cannon, N. Hirao	1986	6

About David Hines

David Hines is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Infectious Diseases, Family Practice and Epidemiology, having authored 30 papers that have together received 766 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (7 papers), Antibiotic Resistance in Bacteria (5 papers), COVID-19 Clinical Research Studies (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Urinary Tract Infections Management (3 papers), Long-Term Effects of COVID-19 (3 papers), Workplace Health and Well-being (2 papers) and Innovations in Medical Education (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (101 citations), Molecular Medicine (155 citations), Infectious Diseases (199 citations), Epidemiology (296 citations) and Clinical Biochemistry (56 citations). David Hines has collaborated with scholars based in United States, Netherlands and Norway. Frequent co-authors include Thomas C. Boone, H. Inoue, K M Zsebo, Arthur M. Cohen, L M Souza, Shayna Weiner, Mark Wolff, E. Lucile White, Michael Y. Lin and Heather Hill. Their work appears in journals such as Open Forum Infectious Diseases, Journal of Occupational and Environmental Medicine, ACR Open Rheumatology, Infection Control and Hospital Epidemiology and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact